Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,100.00
-10.00 (-0.16%)
At close: Jul 31, 2026

KOSDAQ:036480 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
653.72598.19-1,769-679.681,703865.92
Depreciation & Amortization
2,5302,5401,7152,8622,7062,538
Loss (Gain) From Sale of Assets
-4.68-19.04-16.260.07-2,219-7
Loss (Gain) From Sale of Investments
0.090.070.190.290.910.3
Loss (Gain) on Equity Investments
38.738.727.7-36.3914.64.97
Provision & Write-off of Bad Debts
231.25174.93170.8227.0929.4212.07
Other Operating Activities
26.7945.76887.1-342.66881.17367.84
Change in Accounts Receivable
-978.38-1,403229.73-1,130-103.07516.13
Change in Inventory
374.44311.621,536-1,132-1,027-1,417
Change in Accounts Payable
-749.36-190.91-226.87565.26209.1-468.3
Change in Other Net Operating Assets
-338.54-686.04-450.67-1,368-1,039-209.63
Operating Cash Flow
1,7841,4102,103-1,2341,1552,203
Operating Cash Flow Growth
-16.70%-32.95%---47.56%-31.92%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-374.84-355.64-795.32-1,256-2,315-2,968
Sale of Property, Plant & Equipment
5.9119.0518.6459.094,5727
Sale (Purchase) of Intangibles
-0.48-2.45-0.55-3.96-0.39-0.8
Investment in Securities
-1,844-322.852,1971,437-3,415-678.96
Other Investing Activities
00--00
Investing Cash Flow
-2,213-661.891,419235.73-1,158-3,641

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,5001,0003,3192,000700
Long-Term Debt Issued
--15,5003,000-800
Total Debt Issued
1,4851,50016,5006,3192,0001,500
Short-Term Debt Repaid
--1,000-5,319--700-700
Long-Term Debt Repaid
--1,038-15,374-4,553-1,661-172.18
Total Debt Repaid
-2,047-2,038-20,692-4,553-2,361-872.18
Net Debt Issued (Repaid)
-562.45-537.86-4,1921,766-361.29627.82
Dividends Paid
-285-285-285-285-285-323
Other Financing Activities
------0
Financing Cash Flow
-847.45-822.86-4,4771,481-646.29304.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-38.41-110.12222.8428.2105.91316.07
Miscellaneous Cash Flow Adjustments
-0-000-0
Net Cash Flow
-1,315-184.76-731.96510.68-543.44-816.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4091,0541,308-2,490-1,160-764.71
Free Cash Flow Growth
-14.52%-19.37%----
Free Cash Flow Margin
5.45%4.06%5.49%-9.74%-4.55%-3.19%
Free Cash Flow Per Share
370.87277.49344.14-655.25-305.18-201.24
Levered Free Cash Flow
845.8652.321,543-1,862-997.53-1,065
Unlevered Free Cash Flow
1,2181,0312,072-1,304-677.16-891.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
582.13592.29909.4955.25458.48271.46
Cash Income Tax Paid
--6.08-52.12475.446.03-94.73
Change in Working Capital
-1,692-1,9691,088-3,065-1,961-1,579